Release Date: 04/08/16 11:32 Summary: Ceasing to be a substantial holder-BRB.AX Price Sensitive: No Download Document 110.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%